As of Mar 30
| +0.50 / +0.77%|
The 17 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 67.00, with a high estimate of 75.00 and a low estimate of 55.00. The median estimate represents a +1.89% increase from the last price of 65.76.
The current consensus among 23 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.